HOOKIPA Pharma Analyst Ratings
JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Cuts Target Price to $7
Strategic Shift and Partnership Potential Drive Buy Rating for HOOKIPA Pharma
Analysts Are Bullish on These Healthcare Stocks: Hookipa Pharma (HOOK), Cue Biopharma (CUE)
JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Maintains Target Price $24
HOOKIPA Pharma Is Maintained at Outperform by RBC Capital
HOOKIPA Pharma Analyst Ratings
JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Maintains Target Price $24
Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and SCYNEXIS (SCYX)
JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Maintains Target Price $24
JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Maintains Target Price $24
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Replimune Group (REPL) and Hookipa Pharma (HOOK)
HOOKIPA Pharma Analyst Ratings
JMP Securities Maintains Market Outperform on HOOKIPA Pharma, Raises Price Target to $24
Buy Rating and Price Target Increase for Hookipa Pharma Amid Clinical and Financial Progress
HOOKIPA Pharma Analyst Ratings
JMP Securities Maintains Market Outperform on HOOKIPA Pharma, Lowers Price Target to $23
JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Cuts Target Price to $23
Optimistic Outlook for Hookipa Pharma's Oncology Pipeline Prompts Buy Rating
HOOKIPA Pharma Analyst Ratings